In this mixed methods approach, Dr. Rosenzweig and her team quantify how social, cultural and physical factors (including race, racism, poverty, trauma and neighborhood deprivation) comprising allostatic load influences subsequent disease outcomes directly, or are moderated through patient physical, emotional and financial distress. This examination provides risk metrics and patient voice for the creation and testing of a personalized and proactive assessment and supportive intervention protocol. A previous project specifically focused on non-small-cell lung carcinoma (NSCLC) patients. The project was recently renewed and expanded to include all patients in the region with cancers in which survival disparities are present.
(Funding Source: Genetech Equity Fund)